IBR900 Cell Injection

· Imbioray (Hangzhou) Biomedicine Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IBR900 Cell Injection, covering 2025-07-18 to 2025-07-18. Get the full timeline:

Most recent: Clinical Trial Update: The Safety, Tolerability, and Efficacy of IBR900 Cell Injection in Relapsed/Refractory B-cell Non Hodgkin Lymphoma [Phase 1]

See pricing